Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, May 9, 2023
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
Edward White Maintained (SNDX) at Strong Buy with Increased Target to $36 on, May 9th, 2023
Edward White of HC Wainwright & Co., Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Strong Buy with Increased Target from $33 to $36 on, May 9th, 2023.
Edward has made no other calls on SNDX in the last 4 months.
There are 4 other peers that have a rating on SNDX. Out of the 4 peers that are also analyzing SNDX, 0 agree with Edward's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Edward
- Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $36 on, Tuesday, March 7th, 2023
- Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $32 on, Thursday, March 2nd, 2023
- Madhu Kumar of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $34 on, Wednesday, March 1st, 2023
- Bradley Canino of "Stifel" Initiated at Strong Buy and Held Target at $37 on, Tuesday, January 31st, 2023
